← Back to Search

Behavioral Intervention

Mobile Health-based Motivational Interviewing for Vaccine Hesitancy (COVID-19 Trial)

N/A
Waitlist Available
Research Sponsored by Oklahoma State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up follow-up (8 weeks)
Awards & highlights

COVID-19 Trial Summary

This trial tests if a mobile app can help people get vaccinated against COVID-19.

Who is the study for?
This trial is for adults over 18 living in rural areas who haven't had a COVID-19 vaccine and can speak English. They must be able to consent and use a smartphone. It's not for those with certain medical/psychiatric conditions, involved in other COVID studies, or pregnant/lactating women.Check my eligibility
What is being tested?
The study tests if mobile Health-based motivational interviewing (MOTIVACC) encourages people to get vaccinated against COVID-19 more effectively than traditional phone calls. Participants will receive different types of motivational messages.See study design
What are the potential side effects?
Since this trial focuses on communication methods rather than medications, there are no direct side effects from drugs; however, participants may experience discomfort or stress from discussing vaccination.

COVID-19 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~follow-up (8 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and follow-up (8 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in intention to receive the vaccine
Changes in vaccine hesitancy and confidence
Secondary outcome measures
Changes in ambivalence
Changes in expectations related to vaccines
Changes in self-efficacy
+2 more
Other outcome measures
Percentage of total of ecological momentary assessment messages opened/viewed

COVID-19 Trial Design

3Treatment groups
Experimental Treatment
Group I: Standard MIExperimental Treatment2 Interventions
Group II: MOTIVACCExperimental Treatment2 Interventions
Group III: Intensive MIExperimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intensive MI
2009
Completed Phase 2
~220

Find a Location

Who is running the clinical trial?

Oklahoma State UniversityLead Sponsor
46 Previous Clinical Trials
8,212 Total Patients Enrolled

Media Library

MOTIVACC (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05977192 — N/A
Vaccine Hesitancy Research Study Groups: Intensive MI, Standard MI, MOTIVACC
Vaccine Hesitancy Clinical Trial 2023: MOTIVACC Highlights & Side Effects. Trial Name: NCT05977192 — N/A
MOTIVACC (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05977192 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings in this trial that potential participants could occupy?

"Per the information hosted on clinicaltrials.gov, this medical trial is not actively accepting participants as of now. The initial posting was made on August 1st 2023 and the latest update was posted a day later. Despite not being open to enrollment presently, there are 3 other studies that can accommodate new patient applications at this time."

Answered by AI

Who else is applying?

What site did they apply to?
Oklahoma State University
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I would like to try and get people to understand the importance of vaccinations and share my experience.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Mobile Health-based Motivational Interviewing to Promote COVID-19 Vaccination
ABraun 2024. "Mobile Health-based Motivational Interviewing to Promote COVID-19 Vaccination". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05977192.
~40 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top